IXI's autofocusing lenses are almost ready to replace multifocal glasses
Recorded: May 30, 2026, 1:03 p.m.
| Original | Summarized |
IXI’s autofocusing lenses are almost ready to replace multifocal glasses LatestNewsAIAppsComputingMobileSocial MediaEVs & TransportationReviewsSmartphonesLaptops & PCsGamingHeadphonesWearablesPhotographyTabletsHomeBuying GuidesLaptopsHeadphonesSmart HomeGamingGamingNintendoPCPlayStationXboxBig TechAmazonAppleGoogleMetaMicrosoftSamsungEntertainmentTV & MoviesStreamingCybersecurityVPNWearablesTomorrowScienceSpaceRobotics Newsletter About
IXI’s autofocusing lenses are almost ready to replace multifocal glasses LatestNewsAIAppsComputingMobileSocial MediaEVs & TransportationReviewsSmartphonesLaptops & PCsGamingHeadphonesWearablesPhotographyTabletsHomeBuying GuidesLaptopsHeadphonesSmart HomeGamingGamingNintendoPCPlayStationXboxBig TechAmazonAppleGoogleMetaMicrosoftSamsungEntertainmentTV & MoviesStreamingCybersecurityVPNWearablesTomorrowScienceSpaceRobotics
Newsletter Wearables IXI’s autofocusing lenses are almost ready to replace multifocal glasses By Mat Smith Jan. 8, 2026 4:26 pm EST Mat Smith for Engadget While wave upon wave of smartglasses and face-based wearables crash on the shores of CES, traditional glasses really haven't changed much over the hundreds of years we've been using them. The last innovation, arguably, was progressive multifocals that blended near and farsighted lenses — and that was back in the 1950s. It makes sense that autofocusing glasses maker IXI thinks it's time to modernize glasses. IXI's glasses are designed for age-related farsightedness, a condition that affects many, if not most people over 45. They combine cameraless eye tracking with liquid crystal lenses that automatically activate when the glasses detect the user's focus shifting. This means that, instead of having two separate prescriptions, as in multifocal or bifocal lenses, IXI's lenses automatically switch between each prescription. Crucially — like most modern smartglasses — the frames themselves are lightweight and look like just another pair of normal glasses. Mat Smith for Engadget With a row of prototype frames and lenses laid out in front of him, CEO and co-founder Niko Eiden explained the technology, which can be separated into two parts. First, the IXI glasses track the movement of your eyes using a system of LEDs and photodiodes, dotted around the edges of where the lenses sit. The LEDs bounce invisible infrared light off the eyes and then measure the reflection, detecting the subtle movements of your eye and how both eyes converge when focusing on something close. Mat Smith for Engadget Most of the technology, including memory, sensors, driving electronics and eye tracker, is in the front frame of the glasses and part of the arms closest to the hinge. The IXI prototype apparently uses batteries similar in size to those found in AirPods, which gives some sense of the size and weight of the tech being used. The charging port is integrated into the glasses' left arm hinge. Naturally, this does mean they can't be worn while charging. IXI says that a single charge should cover a whole day's usage. Mat Smith for Engadget Hypothetically, the product could even potentially adapt prescriptions dynamically, going beyond the simple vision correction of Gen 1. For example, it could offer stronger corrections as your eyes get fatigued through the day.
Recommended |
IXI is developing autofocusing lenses that possess the potential to supersede traditional multifocal glasses. This innovation stems from the recognition that traditional eyewear has seen limited evolution over centuries, with the most recent significant advancement being progressive multifocals from the 1950s. The startup is currently showcasing working prototypes of its lenses and a 22-gram frame, positioning the technology as a potential game-changer for vision correction. The core functionality of the IXI glasses is designed to address age-related farsightedness, primarily affecting individuals over forty-five. The system operates by combining cameraless eye tracking with liquid crystal lenses that automatically adjust when the device detects a shift in the user's focus. This mechanism eliminates the need for separate prescriptions as found in multifocal or bifocal lenses, allowing the lenses to seamlessly switch between different prescriptions automatically. Niko Eiden, CEO and co-founder of IXI, detailed the technology as comprising two main components. The eye tracking system utilizes LEDs and photodiodes distributed around the lens periphery to measure the reflection of invisible infrared light, thereby detecting subtle eye movements and convergence when focusing. This method is considerably less power-intensive than camera-based systems, utilizing only a small number of analog channels and consuming only four milliwatts while tracking eye movements, blinking, and gaze direction. Most of the supporting technology, including sensors, memory, and driving electronics, is integrated into the front frame and the arms, utilizing battery technology similar to that found in AirPods, allowing a single charge to sustain usage for an entire day. The lenses themselves are constructed from a thin layer of liquid crystal combined with a transparent indium tin oxide conductive layer. This architecture allows the material to transition almost instantly into a prescribed lens, integrating existing prescriptions and even providing cylindrical correction for astigmatism. This thinness facilitates easy integration with existing prescriptions. Beyond basic vision correction, the sensor system provides ancillary health data, as the tracking capabilities allow for the estimation of posture and neck movement, as well as insights into dry eyes and attentiveness. Furthermore, changes in blink rate correlated with focus, daydreaming, and anxiety generate data that can be displayed in a companion application. Hypothetically, this level of data collection could allow the system to dynamically adapt visual corrections, potentially offering stronger adjustments as eye fatigue accumulates throughout the day. IXI is progressing toward commercial viability by pursuing necessary medical certifications and has already established a manufacturing partnership with the Swiss lens-maker Optiswiss. The company intends to market the final product as a high-end luxury glasses option, distributing them through existing opticians, with the goal of launching their first pair next year. |